Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Melisi

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Annals of Surgical Oncology|May 11, 2020
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic AdenocarcinomaIlaria Trestini, Salvatore Paiella, Marta Sandini, et al.
Journal for Immunotherapy of Cancer|March 10, 2021
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancerDavide Melisi, Do-Youn Oh, Antoine Hollebecque, et al.
Future Oncology (London, England)|July 18, 2020
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with <i>FGFR2</i> rearrangementsTanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, et al.
Journal of Geriatric Oncology|December 16, 2018
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world studyValentina Fanotto, Lorenzo Fornaro, Roberto Bordonaro, et al.
Antioxidants (Basel, Switzerland)|April 27, 2024
Nrf2 Plays a Key Role in Erythropoiesis during AgingSerge Cedrick Toya Mbiandjeu, Angela Siciliano, Alessandro Mattè, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 29, 2016
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real worldValentina Fanotto, Stefano Cordio, Giulia Pasquini, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 1, 2018
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening resultsSalvatore Paiella, Roberto Salvia, Matteo De Pastena, et al.
Antioxidants & Redox Signaling|August 11, 2017
Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective ErythropoiesisAlessandro Matte, Luigia De Falco, Enrica Federti, et al.
JAMA Surgery|July 25, 2019
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Giovanni Marchegiani, et al.
Oncotarget|May 29, 2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroupsMichele Simbolo, Matteo Fassan, Andrea Ruzzenente, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Annals of Surgical Oncology|May 11, 2020
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic AdenocarcinomaIlaria Trestini, Salvatore Paiella, Marta Sandini, et al.
Journal for Immunotherapy of Cancer|March 10, 2021
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancerDavide Melisi, Do-Youn Oh, Antoine Hollebecque, et al.
Future Oncology (London, England)|July 18, 2020
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with <i>FGFR2</i> rearrangementsTanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, et al.
Journal of Geriatric Oncology|December 16, 2018
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world studyValentina Fanotto, Lorenzo Fornaro, Roberto Bordonaro, et al.
Antioxidants (Basel, Switzerland)|April 27, 2024
Nrf2 Plays a Key Role in Erythropoiesis during AgingSerge Cedrick Toya Mbiandjeu, Angela Siciliano, Alessandro Mattè, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 29, 2016
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real worldValentina Fanotto, Stefano Cordio, Giulia Pasquini, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 1, 2018
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening resultsSalvatore Paiella, Roberto Salvia, Matteo De Pastena, et al.
Antioxidants & Redox Signaling|August 11, 2017
Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective ErythropoiesisAlessandro Matte, Luigia De Falco, Enrica Federti, et al.
JAMA Surgery|July 25, 2019
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Giovanni Marchegiani, et al.
Oncotarget|May 29, 2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroupsMichele Simbolo, Matteo Fassan, Andrea Ruzzenente, et al.
Pageof 12